• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Probable proline–tRNA ligase, mitochondrial (PARS2)

ACP16390

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16390 Target NamePARS2
Target SynonymsPARS2; Probable proline--tRNA ligase; mitochondrial; EC 6.1.1.15; Prolyl-tRNA synthetase; ProRSFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range30-475
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ7L3T8
Background Information
  • Uniprot Id

    Q7L3T8

  • Target Species

    Human

  • Target Name

    PARS2

  • Target Full Name

    Probable proline--tRNA ligase, mitochondrial

  • Target Subcellular Location

    Mitochondrion matrix.

  • Target Protein Families

    Class-II aminoacyl-tRNA synthetase family

  • Target Synonyms

    PARS2; Probable proline--tRNA ligase; mitochondrial; EC 6.1.1.15; Prolyl-tRNA synthetase; ProRS

  • Target Background

    This gene encodes a putative member of the class II family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of proline to tRNA molecules. Mutations have been found in this gene in some patients with Alpers syndrome.

Inquire Recombinant Human Probable proline–tRNA ligase, mitochondrial (PARS2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification